Insulet
PODD
#1902
Rank
NZ$19.43 B
Marketcap
NZ$280.53
Share price
2.88%
Change (1 day)
-45.71%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): NZ$7.41

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$7.62. In 2025 the company made an earnings per share (EPS) of NZ$6.20 a decrease over its 2024 EPS that were of NZ$10.60.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.4119.42%
2025NZ$6.20-41.47%
2024NZ$10.60102.71%
2023NZ$5.234114.29%
2022NZ$0.12-69.57%
2021NZ$0.41109.09%
2020NZ$0.19-38.89%
2019NZ$0.32200%
2018NZ$0.11-113.04%
2017NZ-$0.82-9.8%
2016NZ-$0.90-60.47%
2015NZ-$2.2938.71%
2014NZ-$1.6512.05%
2013NZ-$1.47-23.15%
2012NZ-$1.91-12.2%
2011NZ-$2.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.49 103.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.40-16.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.36-16.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$50.03 556.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$5.44-171.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.03545-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$4.25-44.19%๐Ÿ‡บ๐Ÿ‡ธ USA